Amedica Corporation to Release Third Quarter 2015 Financial Results and Host Conference Call

SALT LAKE CITY, Oct. 29, 2015 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it will release financial results for its third quarter 2015 on Thursday, November 12, 2015, after the market closes.

Following the release, that same day the Company will host a conference call and simultaneous audio webcast with Dr. Sonny Bal, Chairman and CEO of Amedica Corporation, as well as key members of the management team to review its third quarter 2015 financial results. Details related to this call are as follows:

Date:Thursday, November 12, 2015
Time:5:00 p.m. Eastern Time
Conference ID:69692623
Dial-in: Toll-free (855) 455-6055
International (484) 756-4308
Webcast:Investors section of the Company's website

For those who are not available to listen to the live webcast, a telephone replay will be available for one week following the call by dialing (855) 859-2056 for domestic participants and (404) 537-3406 for international participants. When prompted, please enter the Conference ID number 69692623.The call will also be archived on the investor relations section of the Amedica website under Events & Presentations.

About Amedica Corporation

Amedica is focused on the development and application of medical-grade silicon nitride ceramics. Amedica markets spinal fusion products and is developing a new generation of wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company manufactures its products in its ISO 13485 certified manufacturing facility and, through its partnership with Kyocera, the world's largest ceramic manufacturer. Amedica's spine products are FDA-cleared, CE-marked, and are currently marketed in the U.S. and select markets in Europe and South America through its distributor network and its growing OEM partnerships.

For more information on Amedica or its silicon nitride material platform, please visit

Mike Houston VP, Commercialization 801-839-3534 Robert Haag IRTH Communications 866-976-4784

Source:Amedica Corporation